Lee AJ, Raghavan NS, Bhattarai P, Siddiqui T, Sariya S, Reyes-Dumeyer D, Flowers XE, Cardoso SA, De Jager PL, Bennett DA, Schneider JA et al (2022) FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimers disease
View at PubMed Ballatori N, Krance SM, Notenboom S, et al
It has demonstrated the ability to rapidly increase gene expression in rat excision skin wounds, which may define healing in other tissues
+ Facility Inspections FDA Warning Letters Company: Apothecary Pharma, LLC Type: Compounding pharmacy and FDA-registered outsourcing facilityFDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Warning Letter Date: December 1, 2025